HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Louis M Staudt Selected Research

carboxyl radical (COO-)

1/2021Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinib.
9/2015Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies.
2/2014Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.
6/2011Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Louis M Staudt Research Topics

Disease

76Neoplasms (Cancer)
10/2022 - 01/2002
52Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2021 - 04/2002
37Lymphoma (Lymphomas)
04/2022 - 07/2002
21B-Cell Lymphoma (Lymphoma, B Cell)
12/2021 - 12/2002
12Burkitt Lymphoma (Burkitt's Lymphoma)
10/2020 - 06/2006
10Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2021 - 01/2005
7Disease Progression
10/2021 - 07/2002
6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2021 - 07/2002
6Multiple Myeloma
01/2021 - 08/2007
5Leukemia
05/2017 - 07/2002
4Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
10/2022 - 05/2014
4Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2021 - 01/2005
4Hodgkin Disease (Hodgkin's Disease)
01/2020 - 03/2010
3Genetic Translocation (Chromosomal Translocation)
12/2021 - 12/2002
3Carcinogenesis
11/2009 - 04/2006
2Anemia
01/2021 - 08/2017
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2019 - 05/2014
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2016 - 06/2003
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2013 - 08/2012
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
05/2013 - 08/2012
2Hematologic Neoplasms (Hematological Malignancy)
04/2012 - 05/2006
2Plasmacytoma
11/2005 - 09/2005
2Infections
08/2004 - 04/2004
1Hearing Loss (Hearing Impairment)
04/2022
1Breast Neoplasms (Breast Cancer)
01/2021
1Febrile Neutropenia
01/2021

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2002
16NF-kappa B (NF-kB)IBA
09/2010 - 07/2002
13Rituximab (Mabthera)FDA Link
01/2021 - 01/2007
12ibrutinibIBA
12/2021 - 02/2014
10Biological ProductsIBA
01/2020 - 01/2005
10DNA (Deoxyribonucleic Acid)IBA
10/2018 - 01/2002
9Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 12/2011
9Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 12/2011
9Prednisone (Sone)FDA LinkGeneric
01/2021 - 12/2011
9Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 12/2011
8AntigensIBA
10/2021 - 01/2002
8Biomarkers (Surrogate Marker)IBA
05/2017 - 05/2003
7Transcription Factors (Transcription Factor)IBA
10/2018 - 05/2006
7Complementary DNA (cDNA)IBA
08/2007 - 04/2002
6ParaffinIBA
05/2017 - 06/2011
6Phosphotransferases (Kinase)IBA
04/2016 - 06/2010
5Agammaglobulinaemia Tyrosine KinaseIBA
11/2021 - 04/2015
5CyclinsIBA
01/2021 - 12/2005
5Cyclin D1IBA
01/2021 - 02/2003
5Formaldehyde (Formol)FDA Link
05/2017 - 06/2011
5Messenger RNA (mRNA)IBA
01/2013 - 02/2003
4ChromatinIBA
01/2021 - 01/2012
4carboxyl radical (COO-)IBA
01/2021 - 06/2011
4Interleukin-6 (Interleukin 6)IBA
01/2020 - 09/2005
4Etoposide (VP 16)FDA LinkGeneric
01/2019 - 04/2013
4Immunoglobulin M (IgM)IBA
11/2015 - 04/2004
4MicroRNAs (MicroRNA)IBA
02/2015 - 09/2008
4RNA (Ribonucleic Acid)IBA
01/2013 - 08/2010
4LigandsIBA
07/2012 - 11/2005
4Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
11/2005 - 06/2003
3UbiquitinIBA
12/2021 - 04/2014
3Lenalidomide (CC 5013)FDA Link
01/2021 - 06/2012
3Histones (Histone)IBA
01/2021 - 12/2010
3AntibodiesIBA
01/2019 - 10/2014
3Immunoglobulins (Immunoglobulin)IBA
02/2014 - 12/2002
3Bortezomib (Velcade)FDA Link
08/2012 - 06/2009
3I-kappa B KinaseIBA
06/2010 - 01/2005
3Cyclin D2IBA
11/2009 - 02/2004
2Mechanistic Target of Rapamycin Complex 1IBA
10/2022 - 10/2021
2Ligases (Synthetase)IBA
12/2021 - 01/2015
2Histocompatibility Antigens Class IIBA
12/2021 - 01/2019
2Immunoglobulin Variable RegionIBA
10/2021 - 01/2019
2Protein Isoforms (Isoforms)IBA
01/2021 - 01/2021
2Cyclin D3IBA
10/2020 - 12/2005
2Anaplastic Lymphoma KinaseIBA
11/2019 - 05/2014
2Pharmaceutical PreparationsIBA
07/2019 - 09/2004
2Cytidine DeaminaseIBA
01/2019 - 03/2007
2Interleukin-10 (Interleukin 10)IBA
11/2016 - 04/2008
2Small Interfering RNA (siRNA)IBA
04/2016 - 11/2012
2Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
12/2014 - 02/2014
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2013 - 11/2009
2InterleukinsIBA
05/2013 - 02/2003
2ElementsIBA
11/2012 - 11/2009
2Tetracycline (Achromycin)FDA LinkGeneric
11/2012 - 05/2009
2InterferonsIBA
06/2012 - 04/2007
2MHC class II transactivator proteinIBA
03/2011 - 11/2009
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2009 - 01/2008
2Antigen Receptors (Antigen Receptor)IBA
03/2009 - 03/2008
1eprenetapoptIBA
10/2022
1palbociclibIBA
10/2022
1Sphingosine-1-Phosphate ReceptorsIBA
04/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2021
1Phospholipases (Phospholipase)IBA
11/2021
1DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
10/2021
1IntegrinsIBA
10/2021
1LectinsIBA
10/2021
1Complementarity Determining Regions (Complementarity Determining Region)IBA
10/2021
1Intercellular Adhesion Molecule-3IBA
10/2021
1Polysaccharides (Glycans)IBA
10/2021
1Glucose (Dextrose)FDA LinkGeneric
10/2021
1B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
10/2021

Therapy/Procedure

26Therapeutics
10/2022 - 02/2003
9Drug Therapy (Chemotherapy)
01/2019 - 06/2002
4Precision Medicine
01/2021 - 01/2017